A61K 9/0051
Ocular inserts or implants
Official title: {Ocular inserts or implants}
A61K9/0051 (Ocular inserts or implants) appears on 1,237 US grants and 2,304 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,237
- Published applications
- 2,304
- Assignees
- 648
- Inventors
- 2,726
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 16 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 7 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 8 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 11 | 0 |
| 1999 | 8 | 0 |
| 2000 | 7 | 0 |
| 2001 | 11 | 0 |
| 2002 | 13 | 23 |
| 2003 | 13 | 24 |
| 2004 | 11 | 51 |
| 2005 | 7 | 83 |
| 2006 | 14 | 67 |
| 2007 | 9 | 71 |
| 2008 | 4 | 94 |
| 2009 | 13 | 55 |
| 2010 | 21 | 81 |
| 2011 | 35 | 81 |
| 2012 | 44 | 91 |
| 2013 | 56 | 114 |
| 2014 | 82 | 111 |
| 2015 | 77 | 113 |
| 2016 | 67 | 128 |
| 2017 | 78 | 119 |
| 2018 | 71 | 116 |
| 2019 | 87 | 125 |
| 2020 | 79 | 133 |
| 2021 | 73 | 114 |
| 2022 | 62 | 119 |
| 2023 | 41 | 114 |
| 2024 | 60 | 98 |
| 2025 | 62 | 100 |
| 2026 | 29 | 79 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Elastomeric matrices based on plasticized PVOH compositions and uses thereof22 Sep 2026US 12,740,939 B2aVISI Ltd.
- Ophthalmic device11 Aug 2026US 12,702,587 B2aVISI Ltd.
- Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof11 Aug 2026US 12,702,651 B2Harrow IP, LLC
- Treatments for ocular surface disorders30 Jun 2026US 12,667,586 B2Glaukos Corporation
- Porous nanocomposite medical implant device9 Jun 2026US 12,648,904 B2Lynthera Corporation
- Ocular implant containing a tyrosine kinase inhibitor8 Oct 2026US 2026/0306469 A1Ocular Therapeutix, Inc.
- Lifitegrast-containing ink binder for ophthalmic devices8 Oct 2026US 2026/0306478 A1Bausch + Lomb Ireland Limited
- Ophthalmic device for treatment of dry eye1 Oct 2026US 2026/0294798 A1Bausch + Lomb Ireland Limited
- Histatin for corneal wound healing and ocular surface disease1 Oct 2026US 2026/0295005 A1Visus Therapeutics, Inc.
- Ocular Hydrogel Compositions17 Sep 2026US 2026/0272830 A1The University of Birmingham
Most cited
By later US patents
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Low-permeability, laser-activated drug delivery device1,367US 8,911,426 B2On Demand Therapeutics, Inc. · 2014
- Drug delivery devices, kits and methods therefor1,366US 8,521,273 B22013
- Controlled-release biocompatible ocular drug delivery implant devices and methods780US 6,331,313 B1Oculex Pharmaceticals, Inc. · 2001
- Biocompatible ocular implants713US 5,443,505 AOculex Pharmaceuticals, Inc. · 1995